SQZ BIOTECH
SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.
SQZ BIOTECH
Industry:
Biotechnology Life Science Therapeutics
Founded:
2013-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.sqzbiotech.com
Total Employee:
101+
Status:
Active
Contact:
617-758-8672
Email Addresses:
[email protected]
Total Funding:
229.81 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institute of General Medical Science
National Institute of General Medical Science investment in Grant - SQZ Biotech
Invus
Invus investment in Series D - SQZ Biotech
Polaris Partners
Polaris Partners investment in Series D - SQZ Biotech
Illumina Ventures
Illumina Ventures investment in Series D - SQZ Biotech
JDRF T1D Fund
JDRF T1D Fund investment in Series D - SQZ Biotech
GV
GV investment in Series D - SQZ Biotech
NanoDimension
NanoDimension investment in Series D - SQZ Biotech
Temasek Holdings
Temasek Holdings investment in Series D - SQZ Biotech
GV
GV investment in Series D - SQZ Biotech
Alumni Ventures
Alumni Ventures investment in Series D - SQZ Biotech
Key Employee Changes
Date | New article |
---|---|
2022-07-11 | SQZ Biotechnologies Appoints Micah Zajic as Chief Financial Officer |
Official Site Inspections
http://www.sqzbiotech.com Semrush global rank: 9.59 M Semrush visits lastest month: 136
Unable to get host informations!!!